280 results
Search Results
2. The most influential papers in mitral valve surgery; a bibliometric analysis
- Author
-
Allen, N., O’Sullivan, K., and Jones, J. M.
- Published
- 2020
- Full Text
- View/download PDF
3. Optimising a clinical decision support tool to improve chronic kidney disease management in general practice.
- Author
-
Hunter, Barbara, Davidson, Sandra, Lumsden, Natalie, Chima, Sophie, Gutierrez, Javiera Martinez, Emery, Jon, Nelson, Craig, and Manski-Nankervis, Jo-Anne
- Subjects
TREATMENT of chronic kidney failure ,RISK assessment ,MEDICAL protocols ,FAMILY medicine ,HUMAN services programs ,RESEARCH funding ,MEDICAL informatics ,QUALITATIVE research ,CLINICAL decision support systems ,EVALUATION of human services programs ,INTERVIEWING ,PRIMARY health care ,DECISION making in clinical medicine ,PATIENT care ,JUDGMENT sampling ,DESCRIPTIVE statistics ,CHRONIC kidney failure ,TECHNOLOGY ,ELECTRONIC health records ,MATHEMATICAL models ,COMPUTER-aided diagnosis ,QUALITY assurance ,THEORY ,MEDICAL practice ,USER interfaces ,DISEASE risk factors - Abstract
Background: Early identification and treatment of chronic disease is associated with better clinical outcomes, lower costs, and reduced hospitalisation. Primary care is ideally placed to identify patients at risk of, or in the early stages of, chronic disease and to implement prevention and early intervention measures. This paper evaluates the implementation of a technological intervention called Future Health Today that integrates with general practice EMRs to (1) identify patients at-risk of, or with undiagnosed or untreated, chronic kidney disease (CKD), and (2) provide guideline concordant recommendations for patient care. The evaluation aimed to identify the barriers and facilitators to successful implementation. Methods: Future Health Today was implemented in 12 general practices in Victoria, Australia. Fifty-two interviews with 30 practice staff were undertaken between July 2020 and April 2021. Practice characteristics were collected directly from practices via survey. Data were analysed using inductive and deductive qualitative analysis strategies, using Clinical Performance - Feedback Intervention Theory (CP-FIT) for theoretical guidance. Results: Future Health Today was acceptable, user friendly and useful to general practice staff, and supported clinical performance improvement in the identification and management of chronic kidney disease. CP-FIT variables supporting use of FHT included the simplicity of design and delivery of actionable feedback via FHT, good fit within existing workflow, strong engagement with practices and positive attitudes toward FHT. Context variables provided the main barriers to use and were largely situated in the external context of practices (including pressures arising from the COVID-19 pandemic) and technical glitches impacting installation and early use. Participants primarily utilised the point of care prompt rather than the patient management dashboard due to its continued presence, and immediacy and relevance of the recommendations on the prompt, suggesting mechanisms of compatibility, complexity, actionability and credibility influenced use. Most practices continued using FHT after the evaluation phase was complete. Conclusions: This study demonstrates that FHT is a useful and acceptable software platform that provides direct support to general practice in identifying and managing patients with CKD. Further research is underway to explore the effectiveness of FHT, and to expand the conditions on the platform. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Global prevalence of sexual dysfunction in cardiovascular patients: a systematic review and meta-analysis.
- Author
-
Ziapour, Arash, Kazeminia, Mohsen, Rouzbahani, Mohammad, Bakhshi, Saeedeh, Montazeri, Nafiseh, Yıldırım, Murat, Tadbiri, Hani, Moradi, Farideh, and Janjani, Parisa
- Subjects
SEXUAL dysfunction ,CARDIOVASCULAR diseases ,KEYWORD searching ,CARDIAC patients ,DATABASE searching - Abstract
Background: Sexual dysfunction poses a significant challenge for patients with cardiac conditions. Concerning the prevalence of sexual disorders in cardiovascular patients, several seminal studies conducted in various regions of the world have provided diverse facts and figures pertaining to sexual dysfunction among cardiovascular patients. Therefore, the present study aimed to analyze, summarize, and integrate the findings of seminal studies on the effect of underlying factors and estimate the global rate of sexual disorders in cardiovascular patients. Methods: The present systematic review and meta-analysis included studies conducted in 2003–2023. To find the relevant published academic papers, SID, MagIran, PubMed, Scopus, Web of Science (WOS), and Google Scholar databases were searched for keywords using MeSH/Emtree until January 14, 2023. The GRADEpro software was used to evaluate the quality of evidence. The heterogeneity of studies was checked using the I2 index. Results: An initial number of 2122 studies were found in the first search. Following a precise screening process based on predefined inclusion criteria, a total of 17 studies were deemed suitable for inclusion in the meta-analysis. The global prevalence of sexual disorders in cardiovascular patients was estimated at 62.6% (95% CI: 49.8–73.8%). As the results of the meta-regression showed that as the sample size increased, there was a significant decrease in the overall prevalence of sexual disorders among cardiovascular patients. Additionally, as the study years progressed, both age and JBI score exhibited an upward trend. Conclusion: The present findings showed a high prevalence of sexual disorders among cardiovascular patients. Therefore, it is recommended that experts and health policymakers enhance their focus on effectively preventing and controlling these disorders. Besides the evidence achieved very low certainty, it is important for the treatment team to prioritize the sexual relations of cardiovascular patients and focus on improving their sexual function. This should be seen as an essential aspect of their overall recovery process. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Assessment and management of cardiovascular complications in eating disorders.
- Author
-
Friars, Dara, Walsh, Orla, and McNicholas, Fiona
- Subjects
CARDIOLOGICAL manifestations of general diseases ,BINGE-eating disorder ,EATING disorders ,YOUNG adults ,MENTAL health services ,HEART failure - Abstract
Background: Eating disorders (EDs) are serious conditions predominantly affecting adolescents and young adults (AYAs) and pose a considerable threat to their health and wellbeing. Much of this increased morbidity and mortality is linked to medical compromise, especially cardiovascular abnormalities. Rates of presentation to both community and inpatient medical settings have increased in all age groups following the Covid-19 pandemic and subsequent "lockdowns", with patients presentations being more medically compromised compared to previous years. This has implications for clinicians with regard to the performance of competent cardiovascular assessments and management of findings. Aims: This paper is a practical resource for clinicians working with AYAs in whom EDs may present. It will provide a brief summary of the physiological context in which cardiovascular complications develop, systematically outline these complications and suggest a pragmatic approach to their clinical evaluation. Methods: Relevant literature, guidelines and academic texts were critically reviewed. Conclusions were extracted and verified by a Child and Adolescent Psychiatrist and Adolescent Paediatrician, with suitable expertise in this clinical cohort. Conclusions: The cardiovascular complications in EDs are primarily linked to malnutrition, and patients presenting with Anorexia Nervosa are most often at greatest risk of structural and functional cardiac abnormalities, including aberrations of heart rate and rhythm, haemodynamic changes and peripheral vascular abnormalities. Other cardiovascular abnormalities are secondary to electrolyte imbalances, as seen in patients with Bulimia Nervosa. More recently defined EDs including Avoidant/Restrictive Food Intake Disorder and Binge Eating Disorder are also likely associated with distinct cardiovascular complications though further research is required to clarify their nature and severity. Most cardiovascular abnormalities are fully reversible with nutritional restoration, and normalisation of eating behaviours, including the cessation of purging, though rare cases are linked to cardiac deaths. A detailed clinical enquiry accompanied by a thorough physical examination is imperative to ensure the medical safety of AYAs with EDs, and should be supported by an electrocardiogram and laboratory investigations. Consideration of cardiovascular issues, along with effective collaboration with acute medical teams allows community clinicians identify those at highest risk and minimise adverse outcomes in this cohort. Plain English summary: Eating disorders (EDs) are serious medical conditions predominantly affecting adolescents and young adults (AYAs). They are often associated with considerable threat to the patient's health and wellbeing, with Anorexia Nervosa (AN) having the second highest mortality rate of all mental disorders. The cardiovascular system, which includes the heart and blood vessels, is vulnerable to damage and may contribute to this. There are significant concerns that rates of EDs have been increasing, especially in adolescents. Following the onset of the Covid-19 pandemic and subsequent "lockdowns", there has been an increase in numbers of people of all ages attending community and acute medical settings. Furthermore, presentations are considered to be more medically unwell, with patients presenting with lower weights than previous years. This means that clinicians who might be assessing this group need to be competent in cardiovascular assessments of this cohort. The aim of this paper is to discuss the ways the cardiovascular system is affected in AYAs with various types of EDs, especially AN. The paper aims to provide advice to clinicians on how to assess and cardiovascular problems in this group. This practical summary should be useful to clinicians working in mental health community care who may be less familiar with treating potentially serious physical health problems. The most common cardiovascular issues in young people with low weight or weight loss include slow heart rates, low blood pressure, and problems with sudden changes in blood pressure which can result in fainting. Usually these problems resolve as the patient gains weight. However sometimes more serious changes in heart structure and function may occur and persist causing severe medical issues, like heart failure, which partly explains the high death-rate in AN. For this reason it is important that clinicians know how to spot cardiovascular problems in young people with AN and other EDs and provide them with the best medical care as soon as possible. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Patterns of use, perceptions, and cardiopulmonary health risks of cigar products: a systematic review.
- Author
-
Vargees, Comreen, Stroup, Andrea M., Niznik, Taylor, Dunn, Delaney, Wyatt, Riley, Hoetger, Cosima, Taleb, Ziyad Ben, Cohn, Amy M., Cobb, Caroline O., and Fetterman, Jessica L.
- Subjects
CIGARS ,TOBACCO products ,CIGAR smoking ,PRODUCT reviews ,CARDIOTOXICITY - Abstract
Objective: A systematic review was conducted to evaluate the use patterns, health perceptions, and cardiopulmonary health effects of cigars. Data sources: PubMed and Google Scholar were searched for peer-reviewed articles published between June 2014 and February 2021. Search keywords included cigars, cigarillos, little cigars, and cardiopulmonary health outcomes. Study selection: Of 782 papers identified, we excluded non-English articles, review articles, commentaries, and those without empirical data on cigars. Three coders independently reviewed all articles and compared codes to resolve discrepancies. 93 articles met the inclusion criteria and were included. Data synthesis: Cigars have evolved from premium cigars to encompass little cigars and cigarillos (LCCs). LCCs are available in an array of flavors and at a price advantage, and as a result, are used by different groups compared to premium cigars. LCCs are more frequently used by youth, young adults, and those who identify as Black/African American. LCCs are often used in combination with other tobacco products, alcohol, and cannabis. Despite limited regulation, cigars generate smoke of a similar composition as cigarettes. Among the studies identified, evidence suggests that cigar use is associated with cardiovascular and pulmonary toxicity. Higher all-cause and cancer-related mortalities are associated with cigar use, particularly with more frequent and deeper inhalation, compared to non-tobacco users. Conclusions: LCCs are used more frequently by at-risk groups compared to premium cigars. Recent studies evaluating cigar cardiopulmonary health effects are limited but suggest cigars have similar health risks as conferred by cigarette smoking. With the use of LCCs and targeted marketing on the rise among high-risk groups, there is a critical need for continued research in this area. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. 4D Flow cardiovascular magnetic resonance consensus statement: 2023 update
- Author
-
Bissell, Malenka M., Raimondi, Francesca, Ait Ali, Lamia, Allen, Bradley D., Barker, Alex J., Bolger, Ann, Burris, Nicholas, Carhäll, Carl-Johan, Collins, Jeremy D., Ebbers, Tino, Francois, Christopher J., Frydrychowicz, Alex, Garg, Pankaj, Geiger, Julia, Ha, Hojin, Hennemuth, Anja, Hope, Michael D., Hsiao, Albert, Johnson, Kevin, Kozerke, Sebastian, Ma, Liliana E., Markl, Michael, Martins, Duarte, Messina, Marci, Oechtering, Thekla H., van Ooij, Pim, Rigsby, Cynthia, Rodriguez-Palomares, Jose, Roest, Arno A. W., Roldán-Alzate, Alejandro, Schnell, Susanne, Sotelo, Julio, Stuber, Matthias, Syed, Ali B., Töger, Johannes, van der Geest, Rob, Westenberg, Jos, Zhong, Liang, Zhong, Yumin, Wieben, Oliver, and Dyverfeldt, Petter
- Published
- 2023
- Full Text
- View/download PDF
8. Influence of a chronic beta-blocker therapy on perioperative opioid consumption – a post hoc secondary analysis
- Author
-
Trauzeddel, Ralf F., Rothe, Luisa M., Nordine, Michael, Dehé, Lukas, Scholtz, Kathrin, Spies, Claudia, Hadzidiakos, Daniel, Winterer, Georg, Borchers, Friedrich, Kruppa, Jochen, and Treskatsch, Sascha
- Published
- 2024
- Full Text
- View/download PDF
9. Sex differences in cardiovascular epigenetics—a systematic review.
- Author
-
Hartman, Robin J. G., Huisman, Sarah E., and den Ruijter, Hester M.
- Subjects
CARDIOVASCULAR diseases ,EPIGENETICS - Abstract
Background: Differences in cardiovascular diseases are evident in men and women throughout life and are mainly attributed to the presence of sex hormones and chromosomes. Epigenetic mechanisms drive the regulation of the biological processes that may lead to CVD and are possibly influenced by sex. In order to gain an overview of the status quo on sex differences in cardiovascular epigenetics, we performed a systematic review. Materials and methods: A systematic search was performed on PubMed and Embase for studies mentioning cardiovascular disease, epigenetics, and anything related to sex differences. The search returned 3071 publications to be screened. Primary included publications focused on cardiovascular and epigenetics research. Subsequently, papers were assessed for including both sexes in their studies and checked for appropriate sex stratification of results. Results: Two independent screeners identified 75 papers in the proper domains that had included both sexes. Only 17% (13 papers out of 75) of these publications stratified some of their data according to sex. All remaining papers focused on DNA methylation solely as an epigenetic mechanism. Of the excluded papers that included only one sex, 86% (24 out 28) studied males, while 14% (4 out of 28) studied females. Conclusion: Our overview indicates that the majority of studies into cardiovascular epigenetics do not show their data stratified by sex, despite the well-known sex differences in CVD. All included and sex-stratified papers focus on DNA methylation, indicating that a lot of ground is still to gain regarding other epigenetic mechanisms, like chromatin architecture, and histone modifications. More attention to sex in epigenetic studies is warranted as such integration will advance our understanding of cardiovascular disease mechanisms in men and women. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. How to implement geriatric co-management in your hospital? Insights from the G-COACH feasibility study.
- Author
-
Van Grootven, Bastiaan, Jeuris, Anthony, Jonckers, Maren, Devriendt, Els, Dierckx de Casterlé, Bernadette, Dubois, Christophe, Fagard, Katleen, Herregods, Marie-Christine, Hornikx, Miek, Meuris, Bart, Rex, Steffen, Tournoy, Jos, Milisen, Koen, Flamaing, Johan, and Deschodt, Mieke
- Abstract
Background: Geriatric co-management is advocated to manage frail patients in the hospital, but there is no guidance on how to implement such programmes in practice. This paper reports our experiences with implementing the 'Geriatric CO-mAnagement for Cardiology patients in the Hospital' (G-COACH) programme. We investigated if G-COACH was feasible to perform after the initial adoption, investigated how well the implementation strategy was able to achieve the implementation targets, determined how patients experienced receiving G-COACH, and determined how healthcare professionals experienced the implementation of G-COACH.Methods: A feasibility study of the G-COACH programme was performed using a one-group experimental study design. G-COACH was previously implemented on two cardiac care units. Patients and healthcare professionals participating in the G-COACH programme were recruited for this evaluation. The feasibility of the programme was investigated by observing the reach, fidelity and dose using registrations in the electronic patient record and by interviewing patients. The success of the implementation reaching its targets was evaluated using a survey that was completed by 48 healthcare professionals. The experiences of 111 patients were recorded during structured survey interviews. The experiences of healthcare professionals with the implementation process was recorded during 6 semi-structured interviews and 4 focus groups discussions (n = 27).Results: The programme reached 91% in a sample of 151 patients with a mean age of 84 years. There was a high fidelity for the major components of the programme: documentation of geriatric risks (98%), co-management by specialist geriatrics nurse (95%), early rehabilitation (80%), and early discharge planning (74%), except for co-management by the geriatrician (32%). Both patients and healthcare professionals rated G-COACH as acceptable (95 and 94%) and feasible (96 and 74%). The healthcare professionals experienced staffing, competing roles and tasks of the geriatrics nurse and leadership support as important determinants for implementation.Conclusions: The implementation strategy resulted in the successful initiation of the G-COACH programme. G-COACH was perceived as acceptable and feasible. Fidelity was influenced by context factors. Further investigation of the sustainability of the programme is needed.Trial Registration: ISRCTN22096382 (21/05/2020). [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
11. Impact of canagliflozin combined with metformin therapy on reducing cardiovascular risk in type 2 diabetes patients.
- Author
-
Chen, Xiaoyu, Shu, Yimin, and Lin, Xuebo
- Abstract
Purpose: To investigate the impact and safety of canagliflozin combined with metformin on reducing cardiovascular risk in patients with type 2 diabetes mellitus (T2DM). Methods: A total of 258 patients with T2DM admitted to our hospital from March 2021 to March 2022 were selected and divided into a control group and an observation group using a random number table. The control group received metformin combined with a placebo, while the observation group received canagliflozin combined with metformin therapy. All patients received drug treatment for 52 weeks. The primary endpoint of the study was major adverse cardiovascular events (MACE), including myocardial infarction, ischemic stroke, and cardiovascular death. Other study parameters included safety after medication, severe adverse reactions, levels of glycated hemoglobin (HbA1c), body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and estimated glomerular filtration rate (eGFR). Results: After treatment, HbA1c, FPG, BMI, SBP, and DBP in both groups were lower than before treatment, and those indicators in the observation group were lower than those in the control group (P < 0.05). The eGFR, HDL-C, and LDL-C levels in both groups were higher than before treatment, with the eGFR in the observation group being higher than that in the control group (P < 0.05). The incidence of MACE (myocardial infarction, ischemic stroke, cardiovascular death) in the observation group (5.17%) was significantly lower than that in the control group (12.93%) (HR: 2.16, 95%CI:2.04–2.59, P < 0.05). There were no significant differences in the rates of hospitalization for heart failure (3.45% vs. 1.72%), renal adverse events (4.31% vs. 3.45%), non-cardiovascular death (1.72% vs. 0.86%), all-cause mortality (2.59% vs. 0.86%), and severe adverse reactions (12.07% vs. 9.48%) between the two groups (P > 0.05). Conclusion: In patients with T2DM who received the canagliflozin combined with metformin, the mortality rate of cardiovascular causes was significantly reduced. Compared with metformin monotherapy, there is no significant difference in the incidence of serious adverse reactions, and the safety of medication is better, while the blood sugar, blood pressure, and weight of T2DM patients are more actively improved. For T2DM patients with high risk of cardiovascular disease, the combination of canagliflozin and metformin could have a higher benefit in cardiovascular outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats.
- Author
-
Palfrey, Henry A., Kumar, Avinash, Pathak, Rashmi, Stone, Kirsten P., Gettys, Thomas W., and Murthy, Subramanyam N.
- Subjects
HYPERCHOLESTEREMIA prevention ,TISSUE arrays ,RESEARCH funding ,MAJOR adverse cardiovascular events ,SITAGLIPTIN ,CARDIOTONIC agents ,CARDIOVASCULAR diseases risk factors ,METHIONINE ,OXIDATIVE stress ,RATS ,ANIMAL experimentation ,COLLAGEN ,DIET therapy for heart diseases ,DIABETES ,PHARMACODYNAMICS - Abstract
Background: Cardiovascular disease (CVD) affects millions worldwide and is the leading cause of death among non-communicable diseases. Western diets typically comprise of meat and dairy products, both of which are rich in cholesterol (Cho) and methionine (Met), two well-known compounds with atherogenic capabilities. Despite their individual effects, literature on a dietary combination of the two in the context of CVD are limited. Therefore, studies on the combined effects of Cho and Met were carried out using male Sprague Dawley rats. An additional interest was to investigate the cardioprotective potential of sitagliptin, an anti-type 2 diabetic drug. We hypothesized that feeding a dietary combination of Cho and Met would result in adverse cardiac effects and would be attenuated upon administration of sitagliptin. Methods: Adult male Sprague-Dawley rats were fed either a control (Con), high Met (1.5%), high Cho (2.0%), or high Met (1.5%) + high Cho (2.0%) diet for 35 days. They were orally gavaged with an aqueous preparation of sitagliptin (100 mg/kg/d) or vehicle (water) from day 10 through 35. On day 36, rats were euthanized, and tissues were collected for analysis. Results: Histopathological evaluation revealed a reduction in myocardial striations and increased collagen deposition in hypercholesterolemia (HChol), responses that became exacerbated upon sitagliptin administration. Cardiac pro-inflammatory and pro-fibrotic responses were adversely impacted in similar fashion. The addition of Met to Cho (MC) attenuated all adverse structural and biochemical responses, with or without sitagliptin. Conclusions: Adverse cardiac outcomes in HChol were enhanced by the administration of sitagliptin, and such effects were alleviated by Met. Our findings could be significant for understanding or revisiting the risk-benefit evaluation of sitagliptin in type 2 diabetics, and especially those who are known to consume atherogenic diets. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome
- Author
-
Rashad, Nearmeen M., El-Shal, Amal S., Abomandour, Hala G., Aboelfath, Amr Mostafa Kamel, Rafeek, Mohamed el sayed, Badr, Mohammad Samir, Ali, Ayman E., Yousef, Mohammed S., Fathy, Maha Abdelhamid, and Sharaf el din, Mustafa taha Abdelfattah
- Published
- 2019
- Full Text
- View/download PDF
14. The Malay version of the attitudes and beliefs about cardiovascular disease (ABCD-M) risk questionnaire: a translation, reliability and validation study
- Author
-
Mat Said, Zarudin, Tengku Ismail, Tengku Alina, Abdul Hamid, Anees, Sahathevan, Ramesh, Abdul Aziz, Zariah, and Musa, Kamarul Imran
- Published
- 2022
- Full Text
- View/download PDF
15. Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism.
- Author
-
Li, Yan-Shu, Yang, Ru-Ru, Li, Xin-Ying, Liu, Wei-Wei, Zhao, Yi-Ming, Zu, Ming-Man, Gao, Yi-Hong, Huo, Min-Qi, Jiang, Yu-Ting, and Li, Bing-Yun
- Subjects
AMINO acid metabolism ,VASCULAR smooth muscle ,MUSCLE cells ,CELL migration inhibition ,CELL lines - Abstract
Given the insidious and high-fatality nature of cardiovascular diseases (CVDs), the emergence of fluoride as a newly identified risk factor demands serious consideration alongside traditional risk factors. While vascular smooth muscle cells (VSMCs) play a pivotal role in the progression of CVDs, the toxicological impact of fluoride on VSMCs remains largely uncharted. In this study, we constructed fluorosis model in SD rats and A7R5 aortic smooth muscle cell lines to confirm fluoride impaired VSMCs. Fluoride aggravated the pathological damage of rat aorta in vivo. Then A7R5 were exposed to fluoride with concentration ranging from 0 to 1200 μmol/L over a 24-h period, revealing a dose-dependent inhibition of cell proliferation and migration. The further metabolomic analysis showed alterations in metabolite profiles induced by fluoride exposure, notably decreasing organic acids and lipid molecules level. Additionally, gene network analysis underscored the frequency of fluoride's interference with amino acids metabolism, potentially impacting the tricarboxylic acid (TCA) cycle. Our results also highlighted the ATP-binding cassette (ABC) transporters pathway as a central element in VSMC impairment. Moreover, we observed a dose-dependent increase in osteopontin (OPN) and α-smooth muscle actin (α-SMA) mRNA level and a dose-dependent decrease in ABC subfamily C member 1 (ABCC1) and bestrophin 1 (BEST1) mRNA level. These findings advance our understanding of fluoride as a CVD risk factor and its influence on VSMCs and metabolic pathways, warranting further investigation into this emerging risk factor. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Sirtfood intake in relation to the 10-year risk of major adverse cardiovascular events: a population-based cohort study.
- Author
-
Golzarand, Mahdieh, Estaki, Saghar, Mirmiran, Parvin, and Azizi, Fereidoun
- Subjects
HYDROLASES ,RISK assessment ,CARDIOVASCULAR diseases ,FOOD consumption ,STATISTICAL significance ,MAJOR adverse cardiovascular events ,QUESTIONNAIRES ,ANALYSIS of covariance ,CHI-squared test ,DESCRIPTIVE statistics ,LONGITUDINAL method ,TRANSFERASES ,CONFIDENCE intervals ,DATA analysis software ,BIOMARKERS ,PROPORTIONAL hazards models ,DISEASE risk factors - Abstract
Background: Sirtuins have an important role in the regulation of metabolic and biological processess. Thus, we hypothesized that foods that could activate sirtuins, known as "sirtfood", may improve health status. So, this study was aimed at investigating the association between the amount of sirtfood intake and the risk of major adverse cardiovascular events (MACE). Methods: In this cohort study, 2918 adults who had no history of MACE at the start of the study (2006–2008) participated and were followed up on until 2018. The amount of sirtfoods intake (servings per week) was computed using a validated food frequency questionnaire. Each patient's medical records were evaluated to detect MACE. The Cox proportional hazards model was applied to assess the association between the amount of sirtfood intake and the risk of MACE. Results: The median duration of the study was 10.6 years. The hazard ratio (HR) for the risk of MACE was 0.70 for the second (95% CI: 0.50, 0.98) and 0.60 (95% CI: 0.42, 0.86) for the third tertile of sirtfoods intake compared with the first tertile. This association was nonlinear, and sirtfoods consumption of more than five servings per week did not result in a lower risk of MACE. In addition, there was a significant interaction between age (P-interaction < 0.001) and sirtfoods intake in relation to MACE occurrence. When assessing sirtfood components, compared with the lowest intake, the highest amount of soy (HR: 0.74, 95% CI: 0.56, 0.99) and parsley (HR: 0.62, 95% CI: 0.47, 0.83) intake was related to a lower risk of MACE. Conclusion: Our results indicated an inverse association between a higher amount of sirtfood intake and a lower risk of MACE incidents. This association was nonlinear, and having more than five servings of sirtfood per week did not reduce the risk of MACE any further. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Assessing physiological response mechanisms and the role of psychosocial job resources in the physical activity health paradox: study protocol for the Flemish Employees’ Physical Activity (FEPA) study
- Author
-
Ketels, Margo, De Bacquer, Dirk, Geens, Tom, Janssens, Heidi, Korshøj, Mette, Holtermann, Andreas, and Clays, Els
- Published
- 2019
- Full Text
- View/download PDF
18. Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial.
- Author
-
Wu, Chiung-Jung (Jo), Atherton, John J., MacIsaac, Richard J., Courtney, Mary, Chang, Anne M., Thompson, David R., Kostner, Karam, MacIsaac, Andrew I., d'Emden, Michael, Graves, Nick, and McPhail, Steven M.
- Subjects
TYPE 2 diabetes ,CARDIOVASCULAR diseases ,RANDOMIZED controlled trials ,ACUTE coronary syndrome ,SELF-management (Psychology) ,DIABETIC angiopathies ,TYPE 2 diabetes treatment ,TREATMENT of acute coronary syndrome ,HOME care service statistics ,COMPARATIVE studies ,HOSPITAL care ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,HEALTH self-care ,SELF-efficacy ,TELEMEDICINE ,TELEPHONES ,DISEASE management ,COMORBIDITY ,EVALUATION research ,TREATMENT effectiveness ,PATIENT readmissions ,THERAPEUTICS - Abstract
Background: This paper presents a protocol for a randomised controlled trial of the Cardiac-Diabetes Transcare program which is a transitional care, multi-modal self-management program for patients with acute coronary syndrome comorbid with type 2 diabetes. Prior research has indicated people hospitalised with dual cardiac and diabetes diagnoses are at an elevated risk of hospital readmissions, morbidity and mortality. The primary aim of this study is to evaluate the effectiveness (and cost-effectiveness) of a Cardiac-Diabetes Transcare intervention program on 6-month readmission rate in comparison to usual care.Methods/design: A two-armed, randomised controlled trial with blinded outcome assessment will be conducted to evaluate the comparative effectiveness of two modes of care, including a Usual Care Group and a Cardiac-Diabetes Transcare Intervention (in addition to usual care) Group. The primary outcome is 6-month readmission rate, although a range of secondary outcomes will be collected (including self-efficacy) at baseline, 1, 3 and 6 month reassessments. The intervention group will receive in-hospital education tailored for people recovering from an acute coronary syndrome-related hospital admission who have comorbid diabetes, and they will also receive home visits and telephone follow-up by a trained Research Nurse to reinforce and facilitate disease-management-related behaviour change. Both groups will receive usual care interventions offered or referred from participating hospital facilities. A sample size of 432 participants from participating hospitals in the Australian states of Queensland and Victoria will be recruited for 90% power based on the most conservative scenarios modelled for sample size estimates.Discussion: The study outlined in this protocol will provide valuable insight into the effectiveness of a transitional care intervention targeted for people admitted to hospital with cardiac-related presentations commencing in the inpatient hospital setting and transition to the home environment. The purpose of theory-based intervention comprising face-to-face sessions and telephone follow up for patients with acute coronary syndrome and type 2 diabetes is to increase self-efficacy to enhance self-management behaviours and thus improve health outcomes and reduce hospital readmissions.Trial Registration: This study has been registered with the Australian New Zealand Clinical Trials Registry dated 16/12/2014: ACTRN12614001317684 . [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
19. Are interventions to increase the uptake of screening for cardiovascular disease risk factors effective? A systematic review and meta-analysis.
- Author
-
Cheong, A. T., Liew, S. M., Khoo, E. M., Zaidi, N. F. Mohd, and Chinna, K.
- Subjects
CARDIOVASCULAR diseases risk factors ,CINAHL database ,CONFIDENCE intervals ,HEALTH promotion ,MEDICAL databases ,INFORMATION storage & retrieval systems ,MEDICAL screening ,MEDLINE ,META-analysis ,ONLINE information services ,HEALTH outcome assessment ,REGRESSION analysis ,SYSTEMATIC reviews ,EFFECT sizes (Statistics) ,RANDOMIZED controlled trials ,PRE-tests & post-tests ,CONTROL groups ,RESEARCH bias - Abstract
Background: Cardiovascular disease (CVD) is the leading cause of death globally. However, many individuals are unaware of their CVD risk factors. The objective of this systematic review is to determine the effectiveness of existing intervention strategies to increase uptake of CVD risk factors screening. Methods: A systematic search was conducted through Pubmed, CINAHL, EMBASE and Cochrane Central Register of Controlled Trials. Additional articles were located through cross-checking of the references list and bibliography citations of the included studies and previous review papers. We included intervention studies with controlled or baseline comparison groups that were conducted in primary care practices or the community, targeted at adult populations (randomized controlled trials, non-randomized trials with controlled groups and pre- and post-intervention studies). The interventions were targeted either at individuals, communities, health care professionals or the health-care system. The main outcome of interest was the relative risk (RR) of screening uptake rates due to the intervention. Results: We included 21 studies in the meta-analysis. The risk of bias for randomization was low to medium in the randomized controlled trials, except for one, and high in the non-randomized trials. Two analyses were performed; optimistic (using the highest effect sizes) and pessimistic (using the lowest effect sizes). Overall, interventions were shown to increase the uptake of screening for CVD risk factors (RR 1.443; 95% CI 1.264 to 1.648 for pessimistic analysis and RR 1.680; 95% CI 1.420 to 1.988 for optimistic analysis). Effective interventions that increased screening participation included: use of physician reminders (RR ranged between 1.392; 95% CI 1.192 to 1.625, and 1.471; 95% CI 1.304 to 1. 660), use of dedicated personnel (RR ranged between 1.510; 95% CI 1.014 to 2.247, and 2.536; 95% CI 1.297 to 4.960) and provision of financial incentives for screening (RR 1.462; 95% CI 1.068 to 2.000). Meta-regression analysis showed that the effect of CVD risk factors screening uptake was not associated with study design, types of population nor types of interventions. Conclusions: Interventions using physician reminders, using dedicated personnel to deliver screening, and provision of financial incentives were found to be effective in increasing CVD risk factors screening uptake. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
20. The effects of exercise referral schemes in the United Kingdom in those with cardiovascular, mental health, and musculoskeletal disorders: a preliminary systematic review
- Author
-
Rowley, Nikita, Mann, Steve, Steele, James, Horton, Elizabeth, and Jimenez, Alfonso
- Published
- 2018
- Full Text
- View/download PDF
21. Sex differences in the physiological responses to cardiac rehabilitation: a systematic review.
- Author
-
Bouakkar, J., Pereira, T.J., Johnston, H., Pakosh, M., Drake, J. D. M., and Edgell, H.
- Subjects
CARDIAC rehabilitation ,HEART diseases in women ,AEROBIC capacity ,TREATMENT programs ,EXERCISE therapy ,CARDIAC patients - Abstract
Background: Heart disease is one of the leading causes of death in Canada. Many heart disease patients are referred for cardiac rehabilitation, a multidisciplinary outpatient program often consisting of exercise training. Cardiac rehabilitation has been proven to be a successful secondary preventative measure in reducing mortality and improving overall health in heart disease patients, and its completion is important for both sexes as there is growing evidence that women benefit as much as men, if not more, with regard to mortality. It is important to note that previous studies have shown that healthy men and women respond differently to aerobic and resistance training, possibly due to hormones, body composition, autonomic and/or cardiovascular differences. However, evaluating sex differences in the efficacy of standard cardiac rehabilitation programs has not yet been fully explored with many studies investigating clinical or anthropometric data but not physiological outcomes. This systematic review aimed to investigate physiological differences in male and female heart disease patients after cardiac rehabilitation. The inclusion criteria were purposefully broad to encompass many cardiac rehabilitation scenarios, many cardiac disease states, and various program lengths and intensities with the intention of highlighting strengths and weaknesses of the current body of literature. Methods: To conduct a synthesis without meta-analysis, a search strategy was generated to examine the relationships between heart disease patients, a supervised exercise program, physiological outcomes, and sex differences. The review was registered (Prospero: CRD42021251614) and the following databases were searched from inception to 19 December 2023: APA PsycInfo (Ovid), CINAHL Complete (EBSCOhost), Embase (Ovid), Emcare Nursing (Ovid), Medline All (Ovid; includes PubMed non-Medline), and Web of Science Core Collection. Eighty-eight studies pertaining to fitness, metabolism, body composition, respiratory function, cardiac function and C-reactive protein underwent data extraction. Results and conclusions: Importantly, this review suggests that men and women respond similarly to a wide-range of cardiac rehabilitation programs in most physiological variables. However, many studies discussing maximal oxygen consumption, functional capacity, six-minute walk distances, and grip strength suggest that men benefit more. Further research is required to address certain limitations, such as appropriate statistical methods and type/intensity of exercise interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. A national perspective on cardiovascular diseases in Saudi Arabia.
- Author
-
Alqahtani, Bader A. and Alenazi, Aqeel M.
- Subjects
CARDIOVASCULAR diseases ,AGE groups ,BORDERLANDS ,OLDER people ,HEALTH policy - Abstract
Background: Cardiovascular diseases (CVDs) are common chronic conditions that lead to morbidity and mortality worldwide. However, there are no recent national or regional reports about CVDs in Saudi Arabia. Therefore, this study aimed to estimate the national and regional prevalence rates of CVDs among the Saudi population. Methods: This study used data from an ongoing household health survey conducted by the General Authority for Statistics in 2017. The survey sample comprised 24,012 homes that were determined to be a representative sample of the population and dispersed throughout the 13 administrative areas. A self-reported diagnosis of CVD was collected by asking subjects if they had been diagnosed by a physician. Results: The prevalence of CVDs among the Saudi population aged 15 years and older was 1.6% (n = 236,815). The prevalence is higher in males at 1.9% compared to females at 1.4%. Age is a significant factor, with a gradual increase in CVD prevalence until the age of 50, followed by a sharp rise. The prevalence among the age group (≥ 65 years) was the highest, recording 11% (n = 93,971), followed by the age group (60–64 years) which reached 6.5% (n = 31156.71), and the lowest prevalence was found in the age group (< 40 years) as 1.2% (n = 108,226). When considering regional differences, Makkah has the highest prevalence at 1.9% (n = 85,814), followed by Riyadh at 1.7% (n = 79,191). Conversely, Najran has the lowest prevalence at 0.76% (n = 332), with the Northern Border Region having the second lowest rate at 1,46% (n = 4218) These findings underscore the importance of considering both demographic and regional factors in addressing and managing cardiovascular health in Saudi Arabia. Conclusion: This study provides the most recent estimates of the national and regional prevalence rates of CVDs in Saudi Arabia. The findings suggest that CVDs are more common among older adults, males, and residents of the Makkah region. This information can be used to inform public health policies and interventions to reduce the burden of CVDs in Saudi Arabia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Excess hospitalizations and in-hospital mortality associated with seasonal influenza in Italy: a 11-year retrospective study.
- Author
-
Fattore, Giovanni, Pongiglione, Benedetta, and Vezzosi, Luigi
- Subjects
SEASONAL influenza ,HOSPITAL mortality ,HOSPITAL admission & discharge ,INFLUENZA ,HOSPITAL care - Abstract
Background: Influenza and flu-like syndromes are difficult to monitor because the symptoms are not specific, laboratory tests are not routinely performed, and diagnosis codes are often lacking or incompletely registered in medical records. This may result in an underestimation of hospital admissions, associated costs, and in-hospital mortality. Therefore, this study aimed to estimate the public health and economic burden of hospitalisations associated with influenza in Italy, at the national and regional levels. Methods: This 11-year retrospective study included patients admitted to hospitals for influenza or diagnoses associated with influenza (including respiratory and cardiocirculatory conditions) from 2008/09 to 2018/19. Data on hospitalisations were extracted from the Italian Hospital Discharge Records. Information on weekly influenza-like syndrome incidence and weekly average temperature were used to estimate the burden of influenza in terms of hospital admissions in every Italian region and for different age groups by applying a negative binomial model. The model was also applied to estimate in-hospital mortality and the total costs of influenza and influenza-like hospital admissions. Results: Over the study period, in addition to 3,970 average seasonal admissions coded as influenza, we estimated an average of 21,500 excess hospitalization associated with influenza per season, which corresponds to 36.4 cases per 100,000. Most of the excess hospitalisations concerned older individuals (> 65 years) and children (0–4 years) with 86 and 125 cases per 100,000, respectively. Large variations were observed across regions. Overall, the total estimated hospital burden associated with influenza (including respiratory and cardiocirculatory conditions) was approximately €123 m per year. While the in-hospital mortality for admissions with a primary diagnosis of influenza was very low (~ 150 cases per season), cases increased dramatically for primary diagnoses of influenza and pneumonia (about 9,500 cases per season). The average seasonal in-hospital deaths attributable to influenza were equal to 2,775 cases. Conclusions: Our findings suggest a remarkable underestimation of the burden of influenza, mostly in the older population but not neglectable in younger individuals. Our results may aid the management of current and future flu seasons and should be used for policy making (e.g., vaccine strategies) and operation management choices (e.g., planning and staffing beds during influenza peaks). Overall, the present study supports the need for increased testing for influenza in Italy to tackle the current underestimation of influenza burden. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
- Author
-
Gu, Yimeng, Han, Fangfang, Xue, Mei, Wang, Miyuan, and Huang, Yuxiao
- Subjects
HORMONE therapy for menopause ,CARDIOVASCULAR system ,POSTMENOPAUSE ,VENOUS thrombosis ,THROMBOEMBOLISM - Abstract
Background: Menopause hormone therapy (MHT), as an effective method to alleviate the menopause-related symptoms of women, its benefits, risks, and potential influencing factors for the cardiovascular system of postmenopausal women are not very clear. Objectives: To evaluate cardiovascular benefits and risks of MHT in postmenopausal women, and analyze the underlying factors that affect both. Search strategy: The EMBASE, MEDLINE, and CENTRAL databases were searched from 1975 to July 2022. Selection criteria: Randomized Clinical Trials (RCTs) that met pre-specified inclusion criteria were included. Data collection and analysis: Two reviewers extracted data independently. A meta-analysis of random effects was used to analyze data. Main results: This systematic review identified 33 RCTs using MHT involving 44,639 postmenopausal women with a mean age of 60.3 (range 48 to 72 years). There was no significant difference between MHT and placebo (or no treatment) in all-cause death (RR = 0.96, 95%CI 0.85 to 1.09, I
2 = 14%) and cardiovascular events (RR = 0.97, 95%CI 0.82 to 1.14, I2 = 38%) in the overall population of postmenopausal women. However, MHT would increase the risk of stroke (RR = 1.23, 95%CI 1.08 to 1.41,I2 = 0%) and venous thromboembolism (RR = 1.86, 95%CI 1.39 to 2.50, I2 = 24%). Compared with placebo, MHT could improve flow-mediated arterial dilation (FMD) (SMD = 1.46, 95%CI 0.86 to 2.07, I2 = 90%), but it did not improve nitroglycerin-mediated arterial dilation (NMD) (SMD = 0.27, 95%CI − 0.08 to 0.62, I2 = 76%). Compared with women started MHT more than 10 years after menopause, women started MHT within 10 years after menopause had lower frequency of all-cause death (P = 0.02) and cardiovascular events (P = 0.002), and more significant improvement in FMD (P = 0.0003). Compared to mono-estrogen therapy, the combination therapy of estrogen and progesterone would not alter the outcomes of endpoint event. (all-cause death P = 0.52, cardiovascular events P = 0.90, stroke P = 0.85, venous thromboembolism P = 0.33, FMD P = 0.46, NMD P = 0.27). Conclusions: MHT improves flow-mediated arterial dilation (FMD) but fails to lower the risk of all-cause death and cardiovascular events, and increases the risk of stroke and venous thrombosis in postmenopausal women. Early acceptance of MHT not only reduces the risk of all-cause death and cardiovascular events but also further improves FMD, although the risk of stroke and venous thrombosis is not reduced. There is no difference in the outcome of cardiovascular system endpoints between mono-estrogen therapy and combination therapy of estrogen and progesterone. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
25. Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning.
- Author
-
Zöller, Daniela, Haverkamp, Christian, Makoudjou, Adeline, Sofack, Ghislain, Kiefer, Saskia, Gebele, Denis, Pfaffenlehner, Michelle, Boeker, Martin, Binder, Harald, Karki, Kapil, Seidemann, Christian, Schmeck, Bernd, Greulich, Timm, Renz, Harald, Schild, Stefanie, Seuchter, Susanne A., Tibyampansha, Dativa, Buhl, Roland, Rohde, Gernot, and Trudzinski, Franziska C.
- Subjects
FEDERATED learning ,ALPHA 1-antitrypsin deficiency ,CARDIOVASCULAR diseases risk factors ,CHRONIC obstructive pulmonary disease ,DEATH forecasting ,NOSOLOGY - Abstract
Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory multisystemic disease caused by environmental exposures and/or genetic factors. Inherited alpha-1-antitrypsin deficiency (AATD) is one of the best recognized genetic factors increasing the risk for an early onset COPD with emphysema. The aim of this study was to gain a better understanding of the associations between comorbidities and specific biomarkers in COPD patients with and without AATD to enable future investigations aimed, for example, at identifying risk factors or improving care. Methods: We focused on cardiovascular comorbidities, blood high sensitivity troponin (hs-troponin) and lipid profiles in COPD patients with and without AATD. We used clinical data from six German University Medical Centres of the MIRACUM (Medical Informatics Initiative in Research and Medicine) consortium. The codes for the international classification of diseases (ICD) were used for COPD as a main diagnosis and for comorbidities and blood laboratory data were obtained. Data analyses were based on the DataSHIELD framework. Results: Out of 112,852 visits complete information was available for 43,057 COPD patients. According to our findings, 746 patients with AATD (1.73%) showed significantly lower total blood cholesterol levels and less cardiovascular comorbidities than non-AATD COPD patients. Moreover, after adjusting for the confounder factors, such as age, gender, and nicotine abuse, we confirmed that hs-troponin is a suitable predictor of overall mortality in COPD patients. The comorbidities associated with AATD in the current study differ from other studies, which may reflect geographic and population-based differences as well as the heterogeneous characteristics of AATD. Conclusion: The concept of MIRACUM is suitable for the analysis of a large healthcare database. This study provided evidence that COPD patients with AATD have a lower cardiovascular risk and revealed that hs-troponin is a predictor for hospital mortality in individuals with COPD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Acute effects of resistance-type and cycling-type high-intensity interval training on arterial stiffness, cardiac autonomic modulation and cardiac biomarkers.
- Author
-
Wang, Tianjiao, Mao, Jun, Bo, Shumin, Zhang, Li, and Li, Qing
- Subjects
HIGH-intensity interval training ,ARTERIAL diseases ,HEART beat ,INTERVAL training ,SYSTOLIC blood pressure - Abstract
Background: High-intensity interval training (HIIT) has been shown to enhance cardiovascular health. However, there is a lack of research investigating the specific cardiovascular effects of different HIIT training modes. Therefore, this study aimed to compare the acute effects of cycling-type high intensity interval training (C-HIIT) and resistance-type high intensity interval training (R-HIIT) on arterial stiffness, cardiac autonomic modulation, and cardiac biomarkers in healthy young men. Methods: This is a cross-over randomized trial. Eleven healthy active young men took part in both C-HIIT and R-HIIT. Cardio-ankle vascular index (CAVI), heart rate variability (HRV), and systolic blood pressure (SBP) were measured before, immediately and 30 min after the exercise in C-HIIT and R-HIIT. Meanwhile, blood samples for cardiac troponin-T (cTnT) and amino-terminal pro-B-type natriuretic peptide (NT-proBNP) were assessed using ELISA before, 5min and 35min after exercise. Results: There was a significant time × group interaction effect (P = 0.019, η
p 2 = 0.182) and time main effect for ⊿CAVI (P < 0.001, ηp 2 = 0.729), and R-HIIT resulted in a more significant reduction in ⊿CAVI compared to C-HIIT (− 0.60 ± 0.30, P = 0.043, d = 0.924) immediately after exercise. There was a significant time main effect was observed for SBP (P = 0.001, ηp 2 = 0.304). A significant time main effect for lnHF (P < 0.001, ηp 2 = 0.782), lnRMSSD (P < 0.001, ηp 2 = 0.693), and LF/HF (P = 0.001, ηp 2 = 0.302) of HRV was observed. A significant time main effect was observed for cTnT (P = 0.023, ηp 2 = 0.193) and NT-proBNP (P = 0.001, ηp 2 = 0.334) of cardiac biomarkers. Conclusion: R-HIIT and C-HIIT elicited similar acute responses in cardiac autonomic modulation and cardiac biomarkers. However, R-HIIT was more effective in reducing arterial stiffness in healthy young men. Furthermore, the increase in cardiac biomarkers induced by both C-HIIT and R-HIIT was reversible. Trial registration: The study was prospectively registered on 22 February 2022 at www.chictr.org.cn with identification number ChiCTR2200056897. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
27. Efficacy and safety of statin therapy in kidney transplant recipients: a systematic review and meta-analysis
- Author
-
Bellos, Ioannis, Lagiou, Pagona, Benetou, Vassiliki, and Marinaki, Smaragdi
- Published
- 2024
- Full Text
- View/download PDF
28. DNAm scores for serum GDF15 and NT-proBNP levels associate with a range of traits affecting the body and brain
- Author
-
Gadd, Danni A., Smith, Hannah M., Mullin, Donncha, Chybowska, Ola, Hillary, Robert F., Kimenai, Dorien M., Bernabeu, Elena, Cheng, Yipeng, Fawns-Ritchie, Chloe, Campbell, Archie, Page, Danielle, Taylor, Adele, Corley, Janie, Del C. Valdés-Hernández, Maria, Maniega, Susana Muñoz, Bastin, Mark E., Wardlaw, Joanna M., Walker, Rosie M., Evans, Kathryn L., McIntosh, Andrew M., Hayward, Caroline, Russ, Tom C., Harris, Sarah E., Welsh, Paul, Sattar, Naveed, Cox, Simon R., McCartney, Daniel L., and Marioni, Riccardo E.
- Published
- 2024
- Full Text
- View/download PDF
29. In-hospital cardiac arrest characteristics, causes and outcomes in patients with cardiovascular disease across different departments: a retrospective study
- Author
-
Zhang, Ya, Yu, Yang, Qing, Ping, Liu, Xiaojie, Ding, Yao, Wang, Jingcan, and Ao, Hushan
- Published
- 2024
- Full Text
- View/download PDF
30. Cardiovascular risk factors in Moroccan women: systematic review and meta-analysis
- Author
-
Fatima, Es-sabir, Laila, Lahlou, Bouqoufi, Afaf, Amsdar, Lahoucine, and Obtel, Majdouline
- Published
- 2024
- Full Text
- View/download PDF
31. Gut matters in microgravity: potential link of gut microbiota and its metabolites to cardiovascular and musculoskeletal well-being
- Author
-
Ibrahim, Zeinab, Khan, Naveed A, Siddiqui, Ruqaiyyah, Qaisar, Rizwan, Marzook, Hezlin, Soares, Nelson C., and Elmoselhi, Adel B
- Published
- 2024
- Full Text
- View/download PDF
32. Physical activity modification following a Transient Ischemic Attack in individuals with diabetes
- Author
-
Mavridis, Anastasios, Abzhandadze, Tamar, Viktorisson, Adam, and Sunnerhagen, Katharina S.
- Published
- 2024
- Full Text
- View/download PDF
33. The effect of dietary approaches to stop hypertension (DASH) diet on fatty liver and cardiovascular risk factors in subjects with metabolic syndrome: a randomized controlled trial
- Author
-
Sangouni, Abbas Ali, Hosseinzadeh, Mahdieh, and Parastouei, Karim
- Published
- 2024
- Full Text
- View/download PDF
34. Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database
- Author
-
Davies, Elin Mitford, Buckley, Benjamin J. R., Austin, Philip, Lip, Gregory Y. H., Oni, Louise, McDowell, Garry, and Rao, Anirudh
- Published
- 2024
- Full Text
- View/download PDF
35. Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach
- Author
-
Yang, Chun-Ting, Chong, Kah Suan, Wang, Chi-Chuan, Ou, Huang-Tz, and Kuo, Shihchen
- Published
- 2024
- Full Text
- View/download PDF
36. Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1
- Author
-
Shah, Mohd Zahoor ul haq, Shrivastava, Vinoy Kumar, Muzamil, Showkeen, and Olaniyi, Kehinde S.
- Published
- 2024
- Full Text
- View/download PDF
37. Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis
- Author
-
Tan, Chenlei, Li, Yanhua, Wang, Kexin, Lin, Ying, Chen, Yu, and Zheng, Xuebao
- Published
- 2024
- Full Text
- View/download PDF
38. Cardiovascular and bone health outcomes in older people with subclinical hypothyroidism treated with levothyroxine: a systematic review and meta-analysis
- Author
-
Holley, Mia, Razvi, Salman, Farooq, Mohammed Saif, Dew, Rosie, Maxwell, Ian, and Wilkes, Scott
- Published
- 2024
- Full Text
- View/download PDF
39. A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors
- Author
-
Hernandez, Nathanya Baez, Shliakhtsitsava, Ksenya, Tolani, Drishti, Cochran, Cindy, Butts, Ryan, Bonifacio, Judith, Journey, Elizabeth, Oppenheim, Jenna N., Pennant, Sarah G., Arnold, Kimberly, McCaskill, Terri, and Bowers, Daniel C.
- Published
- 2024
- Full Text
- View/download PDF
40. Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
- Author
-
Casale, Thomas B, Corbridge, Thomas, Germain, Guillaume, Laliberté, François, MacKnight, Sean D, Boudreau, Julien, Duh, Mei S, and Deb, Arijita
- Published
- 2024
- Full Text
- View/download PDF
41. Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies
- Author
-
Ahmad, Aftab and Sabbour, Hani
- Published
- 2024
- Full Text
- View/download PDF
42. The association of low serum uric acid with mortality in older people is modified by kidney function: National Health and Nutrition Examination Survey (NHANES) 1999–2018
- Author
-
Fan, Zhongcheng, Li, Zhongju, Guo, Aixin, and Li, Yang
- Published
- 2024
- Full Text
- View/download PDF
43. Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016–2020
- Author
-
Kirchmayer, Ursula, Marino, Claudia, Feriozzi, Sandro, Massimetti, Carlo, Manzuoli, Micol, Angelici, Laura, Bargagli, Anna Maria, Cascini, Silvia, Addis, Antonio, Davoli, Marina, and Agabiti, Nera
- Published
- 2024
- Full Text
- View/download PDF
44. The prevalence of metabolic syndrome in cardiovascular patients in Iran: a systematic review and meta-analysis.
- Author
-
Salari, Nader, Doulatyari, Peyman Kaikhosro, Daneshkhah, Alireza, Vaisi-Raygani, Aliakbar, Jalali, Rostam, Jamshidi, Parnian kord, Abdi, Alireza, Mohammadi, Masoud, and Kazeminia, Mohsen
- Subjects
METABOLIC syndrome ,META-analysis ,CARDIOVASCULAR disease related mortality ,RANDOM effects model ,CARDIOVASCULAR diseases risk factors ,ETIOLOGY of diseases - Abstract
Background: Cardiovascular disease is the cause of more than 50% of mortalities globally, and this rate has grown by 8.6% since the 60 s. One of the risk factors associated with cardiovascular disease and its resulting mortality rate is the metabolic syndrome. Different studies have reported inconsistent rates for the metabolic syndrome. However, no comprehensive study has been conducted to combine the results of existing studies. Thus, the present study was performed with the aim of determining the prevalence of metabolic syndrome among cardiovascular patients in Iran through a systematic review and meta-analysis. Method: : In this review study, the Scientific Information Database, Google Scholar, Science Direct, Scopus, PubMed, and Web of Science (ISI), databases were searched from January 2005 and until May 2020, to identify and extract related articles. To conduct the analysis, a random effects model was used, and the heterogeneity of the studies was examined using the I
2 index. Data analysis was performed within Comprehensive Meta-Analysis (version 2) software. Results: The prevalence of metabolic syndrome in cardiovascular patients in Iran in the 27 papers examined with a sample size of 44,735 patients was 34.2% (95% CI: 26.8–42.6%). A sensitivity analysis was performed to ensure the stability of the results, these results show that by omitting the prevalence from each study, the overall prevalence (34.2%) does not change significantly. the highest prevalence of metabolic syndrome in studies conducted in the period between 2015 and 2020, and this was reported as 55.3 (95% CI: 47.9–62.3) and the highest prevalence of metabolic syndrome in studies conducted in the methods of diagnosis IDF, and the rate was reported as 48 (95% CI: 36.5–59.8). based on meta-regression as the year of research increased, the prevalence of metabolic syndrome in cardiovascular patients in Iran also increased. However, with the increase in sample size, this prevalence decreased (p < 0.05). Conclusions: The results of this study indicate that metabolic syndrome is high in cardiovascular patients in Iran. Accordingly, by understanding its etiology and supervision at all levels, suitable solutions could be offered by providing feedback to hospitals. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
45. 4D flow cardiovascular magnetic resonance consensus statement.
- Author
-
Dyverfeldt, Petter, Bissell, Malenka, Barker, Alex J., Bolger, Ann F., Carlhäll, Carl-Johan, Ebbers, Tino, Francios, Christopher J., Frydrychowicz, Alex, Geiger, Julia, Giese, Daniel, Hope, Michael D., Kilner, Philip J., Kozerke, Sebastian, Myerson, Saul, Neubauer, Stefan, Wieben, Oliver, and Markl, Michael
- Subjects
- *
BLOOD flow measurement , *HEMODYNAMICS , *MAGNETIC resonance imaging , *QUALITY control , *MAGNETIC resonance angiography - Abstract
Pulsatile blood flow through the cavities of the heart and great vessels is time-varying and multidirectional. Access to all regions, phases and directions of cardiovascular flows has formerly been limited. Four-dimensional (4D) flow cardiovascular magnetic resonance (CMR) has enabled more comprehensive access to such flows, with typical spatial resolution of 1.5x1.5x1.5 - 3x3x3 mm³, typical temporal resolution of 30-40 ms, and acquisition times in the order of 5 to 25 min. This consensus paper is the work of physicists, physicians and biomedical engineers, active in the development and implementation of 4D Flow CMR, who have repeatedly met to share experience and ideas. The paper aims to assist understanding of acquisition and analysis methods, and their potential clinical applications with a focus on the heart and greater vessels. We describe that 4D Flow CMR can be clinically advantageous because placement of a single acquisition volume is straightforward and enables flow through any plane across it to be calculated retrospectively and with good accuracy. We also specify research and development goals that have yet to be satisfactorily achieved. Derived flow parameters, generally needing further development or validation for clinical use, include measurements of wall shear stress, pressure difference, turbulent kinetic energy, and intracardiac flow components. The dependence of measurement accuracy on acquisition parameters is considered, as are the uses of different visualization strategies for appropriate representation of time-varying multidirectional flow fields. Finally, we offer suggestions for more consistent, user-friendly implementation of 4D Flow CMR acquisition and data handling with a view to multicenter studies and more widespread adoption of the approach in routine clinical investigations. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
46. Methylation analysis by targeted bisulfite sequencing in large for gestational age (LGA) newborns: the LARGAN cohort.
- Author
-
Carrizosa-Molina, Tamara, Casillas-Díaz, Natalia, Pérez-Nadador, Iris, Vales-Villamarín, Claudia, López-Martínez, Miguel Ángel, Riveiro-Álvarez, Rosa, Wilhelm, Larry, Cervera-Juanes, Rita, Garcés, Carmen, Lomniczi, Alejandro, and Soriano-Guillén, Leandro
- Subjects
GESTATIONAL age ,KIDNEY development ,BIOMARKERS ,NEWBORN infants ,BIRTH weight ,METHYLATION ,KIDNEYS ,CARDIOVASCULAR system - Abstract
Background: In 1990, David Barker proposed that prenatal nutrition is directly linked to adult cardiovascular disease. Since then, the relationship between adult cardiovascular risk, metabolic syndrome and birth weight has been widely documented. Here, we used the TruSeq Methyl Capture EPIC platform to compare the methylation patterns in cord blood from large for gestational age (LGA) vs adequate for gestational age (AGA) newborns from the LARGAN cohort. Results: We found 1672 differentially methylated CpGs (DMCs) with a nominal p < 0.05 and 48 differentially methylated regions (DMRs) with a corrected p < 0.05 between the LGA and AGA groups. A systems biology approach identified several biological processes significantly enriched with genes in association with DMCs with FDR < 0.05, including regulation of transcription, regulation of epinephrine secretion, norepinephrine biosynthesis, receptor transactivation, forebrain regionalization and several terms related to kidney and cardiovascular development. Gene ontology analysis of the genes in association with the 48 DMRs identified several significantly enriched biological processes related to kidney development, including mesonephric duct development and nephron tubule development. Furthermore, our dataset identified several DNA methylation markers enriched in gene networks involved in biological pathways and rare diseases of the cardiovascular system, kidneys, and metabolism. Conclusions: Our study identified several DMCs/DMRs in association with fetal overgrowth. The use of cord blood as a material for the identification of DNA methylation biomarkers gives us the possibility to perform follow-up studies on the same patients as they grow. These studies will not only help us understand how the methylome responds to continuum postnatal growth but also link early alterations of the DNA methylome with later clinical markers of growth and metabolic fitness. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Home-based high-intensity interval training improves cardiorespiratory fitness: a systematic review and meta-analysis.
- Author
-
Tsuji, Katsunori, Tsuchiya, Yosuke, Ueda, Hisashi, and Ochi, Eisuke
- Subjects
HIGH-intensity interval training ,CARDIOPULMONARY fitness ,AEROBIC capacity ,EXERCISE therapy ,RANDOMIZED controlled trials - Abstract
Background: High-intensity interval training (HIIT) is an effective methods to improve maximal oxygen uptake. However, there is no definitive conclusion about the specific effectiveness of home-based HIIT. This review investigated the effects of home-based HIIT on cardiorespiratory fitness in a systematic review and meta-analysis. Methods: Four electronic databases were searched (PubMed, Cochran database, Web of Science, Igaku Chuo Zasshi) for studies through March 25, 2023. Eligibility criteria include randomized controlled trials of home-based HIIT in adult people regardless disease or handicaped. Comparisons were made between non-exercise controls, laboratory-based HIIT, and moderate-intensity continuous training (MICT). The primary outcome was defined as cardiorespiratory fitness and the secondary outcome was defined as patient-reported outcomes. The standardized mean difference (SMD) with 95% confidence intervals (CIs) was calculated for quantitative indices. The random-effect model was used as the pooling method. Results: Two hundred seven studies were identified, and 15 satisfied the inclusion criteria. The meta-analysis for cardiorespiratory fitness showed superiority of home-based HIIT to non-exercise controls (SMD 0.61, 95% CI: 0.21, 1.02). However, no significant difference in cardiorespiratory fitness was observed between home-based HIIT and lab-based HIIT (SMD: -0.35, 95%CI: -0.73, 0.03). Also, no significant difference was observed between the home-based HIIT and MICT (SMD 0.34, 95% CI: -0.05, 0.73). Conclusion: These results indicated that home-based HIIT was an effective intervention for improving cardiorespiratory fitness in healthy adults and patients. Importantly, this review found no significant differences in cardiorespiratory fitness between home-based HIIT and the group of laboratory HIIT and MICT, highlighting its comparable effectiveness and potential as a practical and valuable exercise intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. Interprofessional collaboration in primary care: what effect on patient health? A systematic literature review.
- Author
-
Bouton, Céline, Journeaux, Manon, Jourdain, Maud, Angibaud, Morgane, Huon, Jean-François, and Rat, Cédric
- Subjects
EVALUATION of medical care ,ONLINE information services ,PSYCHOLOGY information storage & retrieval systems ,CINAHL database ,CARDIOVASCULAR diseases risk factors ,MEDICAL information storage & retrieval systems ,SYSTEMATIC reviews ,MENTAL health ,HEALTH status indicators ,PRIMARY health care ,HEALTH care teams ,INTERPROFESSIONAL relations ,RESEARCH funding ,MEDLINE ,COMORBIDITY ,EVALUATION - Abstract
Background: In a period of change in the organization of primary care, Interprofessional Collaboration (IPC) is presented as one of the solutions to health issues. Although the number of inter-professional interventions grounded in primary care increases in all developed countries, evidence on the effects of these collaborations on patient-centred outcomes is patchy. The objective of our study was to assess the effects of IPC grounded in the primary care setting on patient-centred outcomes. Methods: We conducted a systematic literature review using the PubMed, Embase, PsycINFO and CINAHL databases from 01/01/1995 to 01/03/2021, according to the PRISMA guidelines. Studies reporting the effects of IPC in primary care on patient health outcomes were included. The quality of the studies was assessed using the revised Downs and Black checklist. Results: Sixty-five articles concerning 61 interventions were analysed. A total of 43 studies were prospective and randomized. Studies were classified into 3 main categories as follows: 1) studies with patients at cardiovascular risk (28 studies)—including diabetes (18 studies) and arterial hypertension (5 studies); 2) studies including elderly and/or polypathological patients (18 studies); and 3) patients with symptoms of mental or physical disorders (15 studies). The number of included patients varied greatly (from 50 to 312,377). The proportion of studies that reported a positive effect of IPC on patient-centred outcomes was as follows: 23 out of the 28 studies including patients at cardiovascular risk, 8 out of the 18 studies of elderly or polypathological patients, and 11 out of the 12 studies of patients with mental or physical disorders. Conclusions: Evidence suggests that IPC is effective in the management of patients at cardiovascular risk. In elderly or polypathological patients and in patients with mental or physical disorders, the number of studies remains very limited, and the results are heterogeneous. Researchers should be encouraged to perform studies based on comparative designs: it would increase evidence on the positive effect and benefits of IPC on patient variables. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. New global guidelines on sedentary behaviour and health for adults: broadening the behavioural targets
- Author
-
Dempsey, Paddy C., Biddle, Stuart J. H., Buman, Matthew P., Chastin, Sebastien, Ekelund, Ulf, Friedenreich, Christine M., Katzmarzyk, Peter T., Leitzmann, Michael F., Stamatakis, Emmanuel, van der Ploeg, Hidde P., Willumsen, Juana, and Bull, Fiona
- Published
- 2020
- Full Text
- View/download PDF
50. Examining healthcare professionals’ beliefs and actions regarding the physical health of people with schizophrenia
- Author
-
Berry, Alexandra, Drake, Richard J., and Yung, Alison R.
- Published
- 2020
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.